These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 1653785

  • 1. In vivo detection of somatostatin receptors in patients with functionless pituitary adenomas by means of a radioiodinated analog of somatostatin ([123I]SDZ 204-090).
    Faglia G, Bazzoni N, Spada A, Arosio M, Ambrosi B, Spinelli F, Sara R, Bonino C, Lunghi F.
    J Clin Endocrinol Metab; 1991 Oct; 73(4):850-6. PubMed ID: 1653785
    [Abstract] [Full Text] [Related]

  • 2. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
    Bertherat J, Brue T, Enjalbert A, Gunz G, Rasolonjanahary R, Warnet A, Jaquet P, Epelbaum J.
    J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
    [Abstract] [Full Text] [Related]

  • 3. The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status.
    Reubi JC, Landolt AM.
    J Clin Endocrinol Metab; 1989 Apr; 68(4):844-50. PubMed ID: 2537844
    [Abstract] [Full Text] [Related]

  • 4. Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas.
    Bertherat J, Chanson P, Dewailly D, Dupuy M, Jaquet P, Peillon F, Epelbaum J.
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1577-83. PubMed ID: 7903312
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Internalization of the radioiodinated somatostatin analog [125I-Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide.
    Hofland LJ, van Koetsveld PM, Waaijers M, Zuyderwijk J, Breeman WA, Lamberts SW.
    Endocrinology; 1995 Sep; 136(9):3698-706. PubMed ID: 7649075
    [Abstract] [Full Text] [Related]

  • 7. Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas.
    Moyse E, Le Dafniet M, Epelbaum J, Pagesy P, Peillon F, Kordon C, Enjalbert A.
    J Clin Endocrinol Metab; 1985 Jul; 61(1):98-103. PubMed ID: 2860120
    [Abstract] [Full Text] [Related]

  • 8. High density of somatostatin receptors in pituitary tumors from acromegalic patients.
    Reubi JC, Landolt AM.
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1148-51. PubMed ID: 6092412
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analog.
    Bertherat J, Chanson P, Dewailly D, Enjalbert A, Jaquet P, Kordon C, Peillon F, Timsit J, Epelbaum J.
    Horm Res; 1992 Dec; 38(1-2):94-9. PubMed ID: 1306525
    [Abstract] [Full Text] [Related]

  • 11. Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses.
    Reubi JC, Heitz PU, Landolt AM.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):65-73. PubMed ID: 3034958
    [Abstract] [Full Text] [Related]

  • 12. Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitro.
    Tulipano G, Bonfanti C, Milani G, Billeci B, Bollati A, Cozzi R, Maira G, Murphy WA, Poiesi C, Turazzi S, Giustina A.
    Neuroendocrinology; 2001 May; 73(5):344-51. PubMed ID: 11399907
    [Abstract] [Full Text] [Related]

  • 13. Plasma growth hormone responses to somatostatin (SRIH) and SRIH receptors in pituitary adenomas in acromegalic patients.
    Ikuyama S, Nawata H, Kato K, Ibayashi H, Nakagaki H.
    J Clin Endocrinol Metab; 1986 Apr; 62(4):729-33. PubMed ID: 2869049
    [Abstract] [Full Text] [Related]

  • 14. Evidence for multiple protein constituents of the somatostatin receptor in pituitary tumor cells: affinity cross-linking and molecular characterization.
    Murthy KK, Srikant CB, Patel YC.
    Endocrinology; 1989 Aug; 125(2):948-56. PubMed ID: 2568926
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Somatostatin receptor imaging in somatotroph and non-functioning pituitary adenomas: correlation with hormonal and visual responses to octreotide.
    Broson-Chazot F, Houzard C, Ajzenberg C, Nocaudie M, Duet M, Mundler O, Marchandise X, Epelbaum J, Gomez De Alzaga M, Schäfer J, Meyerhof W, Sassolas G, Warnet A.
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):589-98. PubMed ID: 9425399
    [Abstract] [Full Text] [Related]

  • 18. [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation.
    Bakker WH, Albert R, Bruns C, Breeman WA, Hofland LJ, Marbach P, Pless J, Pralet D, Stolz B, Koper JW.
    Life Sci; 1991 Nov; 49(22):1583-91. PubMed ID: 1658515
    [Abstract] [Full Text] [Related]

  • 19. Characterization of growth hormone-releasing hormone receptors in pituitary adenomas from patients with acromegaly.
    Ikuyama S, Natori S, Nawata H, Kato K, Ibayashi H, Kariya T, Sakai T, Rivier J, Vale W.
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1265-71. PubMed ID: 2836473
    [Abstract] [Full Text] [Related]

  • 20. Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity, and in vivo application in animals.
    Bakker WH, Krenning EP, Breeman WA, Koper JW, Kooij PP, Reubi JC, Klijn JG, Visser TJ, Docter R, Lamberts SW.
    J Nucl Med; 1990 Sep; 31(9):1501-9. PubMed ID: 1975618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.